Hrishi Srinagesh

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Hrishi Srinagesh is an author at Stanford University specializing in hematologic malignancy car t-cell therapy, car t cell trials, and cellular immunology.

Publications per year

2024–2024

Publications

CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results

Liora M. Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer et al. · Leukemia · 2024 · 40 citations · Full text

Life Sciences, Hematology, Immunology +15

Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma

Sushma Bharadwaj, Eric Lau, Mark Hamilton et al. · Journal for ImmunoTherapy of Cancer · 2024 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

1–2 of 2